Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 33


Understanding diabetes in patients with HIV/AIDS.

Kalra S, Kalra B, Agrawal N, Unnikrishnan A.

Diabetol Metab Syndr. 2011 Jan 14;3(1):2. doi: 10.1186/1758-5996-3-2.


Comparative Effectiveness and Toxicity of Statins Among HIV-Infected Patients.

Singh S, Willig JH, Mugavero MJ, Crane PK, Harrington RD, Knopp RH, Kosel BW, Saag MS, Kitahata MM, Crane HM.

Clin Infect Dis. 2011 Feb 1;52(3):387-95. doi: 10.1093/cid/ciq111. Epub 2010 Dec 28.


Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control.

Rodbard HW, Jellinger PS, Davidson JA, Einhorn D, Garber AJ, Grunberger G, Handelsman Y, Horton ES, Lebovitz H, Levy P, Moghissi ES, Schwartz SS.

Endocr Pract. 2009 Sep-Oct;15(6):540-59. Erratum in: Endocr Pract. 2009 Nov-Dec;15(7):768-70.


Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America.

Aberg JA, Kaplan JE, Libman H, Emmanuel P, Anderson JR, Stone VE, Oleske JM, Currier JS, Gallant JE; HIV Medicine Association of the Infectious Diseases Society of America.

Clin Infect Dis. 2009 Sep 1;49(5):651-81. doi: 10.1086/605292.


Approach to the human immunodeficiency virus-infected patient with lipodystrophy.

Brown TT.

J Clin Endocrinol Metab. 2008 Aug;93(8):2937-45. doi: 10.1210/jc.2008-1019. Review.


HIV therapy and diabetes risk.

Dagogo-Jack S.

Diabetes Care. 2008 Jun;31(6):1267-8. doi: 10.2337/dc08-0459. No abstract available.


Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.

De Wit S, Sabin CA, Weber R, Worm SW, Reiss P, Cazanave C, El-Sadr W, Monforte Ad, Fontas E, Law MG, Friis-Møller N, Phillips A; Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.

Diabetes Care. 2008 Jun;31(6):1224-9. doi: 10.2337/dc07-2013. Epub 2008 Feb 11.


European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV.

Lundgren JD, Battegay M, Behrens G, De Wit S, Guaraldi G, Katlama C, Martinez E, Nair D, Powderly WG, Reiss P, Sutinen J, Vigano A; EACS Executive Committee.

HIV Med. 2008 Feb;9(2):72-81. doi: 10.1111/j.1468-1293.2007.00534.x.


Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186.

Gerber JG, Kitch DW, Fichtenbaum CJ, Zackin RA, Charles S, Hogg E, Acosta EP, Connick E, Wohl D, Kojic EM, Benson CA, Aberg JA.

J Acquir Immune Defic Syndr. 2008 Apr 1;47(4):459-66. Erratum in: J Acquir Immune Defic Syndr. 2009 Mar 1;50(3):343.


A randomized placebo-controlled trial of metformin for the treatment of HIV lipodystrophy.

Kohli R, Shevitz A, Gorbach S, Wanke C.

HIV Med. 2007 Oct;8(7):420-6.


Megestrol acetate in cachexia and anorexia.

Yeh SS, Schuster MW.

Int J Nanomedicine. 2006;1(4):411-6. Review.


Bezafibrate for the treatment of hypertriglyceridemia in HIV1-infected patients on highly active antiretroviral therapy.

Geraix J, de Souza ME, Delatim FC, Pereira PC.

Braz J Infect Dis. 2006 Jun;10(3):159-64.


Achieving American Diabetes Association goals in HIV-seropositive patients with diabetes mellitus.

Bury JE, Stroup JS, Stephens JR, Baker DL.

Proc (Bayl Univ Med Cent). 2007 Apr;20(2):118-23.


Effects of a nucleoside reverse transcriptase inhibitor, stavudine, on glucose disposal and mitochondrial function in muscle of healthy adults.

Fleischman A, Johnsen S, Systrom DM, Hrovat M, Farrar CT, Frontera W, Fitch K, Thomas BJ, Torriani M, Côté HC, Grinspoon SK.

Am J Physiol Endocrinol Metab. 2007 Jun;292(6):E1666-73. Epub 2007 Feb 6.


Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population.

Mondy K, Overton ET, Grubb J, Tong S, Seyfried W, Powderly W, Yarasheski K.

Clin Infect Dis. 2007 Mar 1;44(5):726-34. Epub 2007 Jan 22.


Effects of high-intensity endurance and resistance exercise on HIV metabolic abnormalities: a pilot study.

Robinson FP, Quinn LT, Rimmer JH.

Biol Res Nurs. 2007 Jan;8(3):177-85.


CD4+ count-guided interruption of antiretroviral treatment.

Strategies for Management of Antiretroviral Therapy (SMART) Study Group, El-Sadr WM, Lundgren J, Neaton JD, Gordin F, Abrams D, Arduino RC, Babiker A, Burman W, Clumeck N, Cohen CJ, Cohn D, Cooper D, Darbyshire J, Emery S, Fätkenheuer G, Gazzard B, Grund B, Hoy J, Klingman K, Losso M, Markowitz N, Neuhaus J, Phillips A, Rappoport C.

N Engl J Med. 2006 Nov 30;355(22):2283-96.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk